AATOD Frequently Asked Questions http://www.aatod.org/resources/frequently-asked-questions/ |
AATOD Guidelines for Addressing Benzodiazepine Use in Opioid Treatment Programs http://www.aatod.org/guidelines-for-addressing-benzodiazepine-use-in-opioid-treatment-programs-otps/ |
AATOD Guidelines for Guest Medication July 2013. http://www.aatod.org/policies/policy-statements/aatod-guidelines-for-guest-medication |
AATOD Medication-Assisted Treatment for Opioid Abuse Disorder in the Criminal Justice System Fact Sheet http://www.aatod.org/policies/fact-sheets/medication-assisted-treatment-for-opioid-use-disorder-in-the-criminal-justice-system/ |
AATOD Policy Paper – Increasing Access to Medications to Treat Opioid Addiction July 2014. ![]() |
AATOD Proposal to Increase Medicaid Utilization for OTPs http://www.aatod.org/policies/policy-statements/proposal-to-increase-medicaid-utilization-for-otps/ |
AATOD White Paper – “Increasing Access to Medication Assisted Treatment for Opioid Addiction in Drug Courts and Correctional Facilities and Working Effectively with Family Courts and Child Protective Services” American Association for the Treatment of Opioid Addiction – July 2016. Please click HERE to view this whitepaper. |
AATOD White Paper-“Integrated Service Delivery Models for Opioid Treatment Programs in an Era of Increasing Opioid Addiction, Health Reform and Parity” American Association for the Treatment of Opioid Addiction – July 2016. ![]() ![]() ![]() |
About Methadone SAMHSA September 2015. Topics include what it is, how it works, how a patient can receive it, methadone safety, side effeccts, pregnancy and breastfeeding, and women and methadone. http://www.samhsa.gov/medication-assisted-treatment/treatment/methadone |
Acute Pain Management for Patients Receiving Maintenance Methadone or Buprenorphine Therapy Annals of Internal Medicine 2006. ![]() ![]() ![]() |
Adult Drug Courts and Medication-Assisted Treatment for Opioid Dependence SAMHSA Summer 2014. ![]() ![]() ![]() |
![]() ![]() ![]() American Medical Association June 2013. ![]() ![]() ![]() |
Advancing Service Integration in Opioid Treatment Programs for the Care and Treatment of Hepatitis C Infection International Journal of Clinical Medicine January 2014. http://www.scirp.org/journal/PaperInformation.aspx?PaperID=42589#.UzNWuJtALzY |
Advocates for Recovery Medicare Infographic August 2018. ![]() ![]() ![]() |
![]() ![]() ![]() Legal Action Center March 2015. ![]() ![]() ![]() |
Benzodiazepine Use and Medication-Assisted Treatment Infographic Institute for Research, Education, and Training in Addictions (IRETA) April 2014. ![]() ![]() ![]() |
Benzodiazepine Use and Misuse Among Patients in a Methadone Program Chen et al.: Benzodiazepine Use and Misuse Among Patients in a Methadone Program. BMC Psychiatry 2011 11:90. ![]() ![]() ![]() |
CESAR FAX Buprenorphine Series March 2003 – December 2014 (Updated January 2015). ![]() ![]() ![]() |
CLINICAL GUIDANCE FOR TREATING PREGNANT AND PARENTING WOMEN WITH OPIOID USE DISORDER AND THEIR INFANTS Substance Abuse Mental Health Services Administration (SAMHSA) January 2018. ![]() ![]() ![]() |
![]() ![]() ![]() American Medical Assocation April 23, 2015. ![]() ![]() ![]() |
Confronting an Epidemic: The Case for Eliminating Barriers to Medication-Assisted Treatment of Heroin and Opioid Addiction Legal Action Center March 2015. ![]() ![]() ![]() |
![]() ![]() ![]() Journal of the American Medical Association February 26, 2014. http://jama.jamanetwork.com/article.aspx?articleID=1838170 |
|
Distance Traveled and Cross-State Commuting to Opioid Treatment Programs in the United States Journal of Environmental and Public Health. This study examined commuting patterns among 23,141 methadone patients enrolling in 84 opioid treatment programs (OTPs) in the United States from 2005-2009. ![]() ![]() ![]() |
![]() ![]() ![]() <journal listings¦> |
“Exploring the World of Opioid Dependency” DVD![]() ![]() ![]() Exploring the World of Opioid Dependency is a new informational video (running time: approx: 15 min) produced exclusively for the Opioid Treatment Providers of Georgia (OTPG) and it\’s members. It is an informative and emotional overview of addiction, it\’s impact on lives and most importantly, the treatment solutions and healing that is possible. Order the stigma-reduction DVD, “Exploring the World of Opioid Dependency,” here. The cost is $20 for non-OTPG members. |
Facing Addiction in America – The Surgeon General’s Report U.S. Surgeon General November 2016. https://addiction.surgeongeneral.gov |
Federal Guidelines for Opioid Treatment Programs SAMHSA March 2015. ![]() ![]() ![]() |
GAO Report to Majority Leader, U.S. Senate – Opioid Use Disorders – HHS Needs Measures to Assess the Effectiveness of Efforts to Expand MAT |
NEWIMG1-Healthy Pregnancy Healthy Baby Fact Sheets This series of four fact sheets emphasizes the importance of continuing a mother’s treatment for opioid use disorder (OUD) throughout pregnancy. The series includes information on OUD and pregnancy, OUD treatment, neonatal abstinence syndrome, and considerations to address before hospital discharge. Opioid Use Disorder and Pregnancy | pdf (85.26 KB) Treating Opioid Use Disorder During Pregnancy | pdf (89.2 KB) Treating Babies Who Were Exposed to Opioids Before Birth | pdf (81.65 KB)G Good Care While Receiving Opioid Use Disorder Treatment | pdf (83.78 KB) Source: SAMHSA.gov – August 2018 |
NEWIMG1-Jail-Based Medication-Assisted Treatment Promising Practices, Guidelines and Resources For the Field |
Legality of Denying Access to Medication Assisted Treatment in the Criminal Justice System![]() ![]() ![]() Legal Action Center October 2011. This report examines the prevalence of opiate addiction in the criminal justice system, its devastating consequences, and the widespread denial of access to one of its most effective forms of treatment: medication assisted treatment (“MAT”). The report then analyzes the circumstances in which the denial of MAT violates Federal anti-discrimination laws and the United States Constitution. ![]() ![]() ![]() |
![]() ![]() ![]() National Institute on Drug Abuse November 2015. http://www.drugabuse.gov/news-events/nida-notes/2015/11/long-term-follow-up-medication-assisted-treatment-addiction-to-pain-relievers-yields-cause-optimism |
MAT With Methadone or Buprenorphine: Assessing the Evidence for Effectiveness AT Forum February 2014. http://staging3.atforum.com/2014/02/mat-with-methadone-or-buprenorphine-assessing-the-evidence-for-effectiveness/ |
Medicaid Coverage and Financing of Medication to Treat Alcohol and Opioid Use Disorders SAMHSA June 2014. ![]() ![]() ![]() |
![]() ![]() ![]() February 2014. ![]() ![]() ![]() |
Medication-Assisted Treatment for Opioid Addiction in Opioid Addiction Treatment Programs Knowledge Application Program (KAP) Keys for Clinicians Based on TIP 43 SAMHSA May 2007. ![]() ![]() ![]() |
M![]() ![]() ![]() SAMHSA May 2007. This Quick Guide is based on TIP 43 and is designed to meet the needs of the busy clinician for concise, easily accessed how-to information. ![]() ![]() ![]() |
![]() ![]() ![]() November 2005. ![]() ![]() ![]() |
Medication-Assisted Treatment: Special Anti-Discrimination Issues Webinar Legal Action Center. For further information go to: http://lac.org/resources/substance-use-resources/medication-assisted-treatment-resources/webinar-medication-assisted-treatment-special-anti-discrimination-issues/ |
Medication-Assisted Treatment of Opioid Use Disorder Pocket Guide SAMHSA March 2016. ![]() ![]() ![]() |
![]() ![]() ![]() Psychiatric Services February 1, 2014. ![]() ![]() ![]() |
![]() ![]() ![]() American Society of Addiction Medicine (ASAM) April 2014. ![]() ![]() ![]() |
Methadone and Buprenorphine 101: A Guide for Law Enforcement HuffingtonPost.com April 15, 2015. The article can be accessed at: http://www.huffingtonpost.com/tessie-castillo/methadone-and-buprenorphi_b_7070438.html |
![]() ![]() ![]() National Institute on Drug Abuse (NIDA) May, 29, 2015. The article can be accessed at: http://www.drugabuse.gov/news-events/news-releases/2015/05/methadone-maintenance-in-prison-results-in-treatment-retention-lower-drug-usage-following-release |
“Methadone in the Treatment of Narcotic Addiction” Andrew Byrne, MD This book is a good read for physicians and other health care workers interested in a broad understanding of addiction and methadone maintenance. Byrne presents his experiences gathered from over a decade of practice in the field in a straightforward, fact-filled manner. View web book online |
Myths vs. Facts: The truth about medication-assisted treatment for opioid addiction |
Neonatal Abstinence Syndrome: How States Can Help Advance the Knowledge Base for Primary Prevention and Best Practices of Care Association of State and Territorial Health Officials March 2014. ![]() ![]() ![]() |
![]() ![]() ![]() Patrick, S.W., Buntin, M.B., Martin, P.R., Scott, T.A., Dupont, W., Richards, M. & Cooper, W.O. (2018) Barriers to Accessing Treatment for Pregnant Women with Opioid Use Disorder in Appalachian States. Substance Abuse, DOI: 10.1080/08897077.2018.1488336 ![]() ![]() ![]() |
Research: Policies Related to Opioid Agonist Therapy for Opioid Use Disorders: The Evolution of State Policies from 2004 to 2013 Journal of Substance Abuse November 2015. Article available online at: http://www.tandfonline.com/doi/full/10.1080/08897077.2015.1080208 |
The ASAM National Practice Guideline For the Use of Medications in the Treatment of Addiction Involving Opioid Use![]() ![]() ![]() American Society of Addiction Medicine June 2015. ![]() ![]() ![]() |
The ASAM National Practice Guideline JAMA Article September/October 2015. http://www.asam.org/practice-support/guidelines-and-consensus-documents/npg/jam-article |
The ASAM National Practice Guideline Pocket Guide http://www.asam.org/docs/default-source/default-document-library/asam-national-practice-guideline-pocketguide.pdf?sfvrsn=0 |
The ASAM National Practice Guideline Phone and Tablet app http://asam.guidelinecentral.com/ |
The ASAM National Practice Guideline Slide Deck http://www.asam.org/practice-support/guidelines-and-consensus-documents/npg/slide-deck |
The President’s Commission on Combating Drug Addiction and the Opioid Crisis April 2017. ![]() ![]() ![]() |
Opioid Fact Sheet National Association of State and Alcohol Abuse Directors (NASAAD) February 2015. ![]() ![]() ![]() |
Proven Clinical and Cost Effectiveness of Medications To Treat Opioid Use Disorder American Society of Addiction Medicine April 2014. ![]() ![]() ![]() |
Providers’ Clinical Support System For Medication Assisted Treatment (PCSS-MAT) PCSS-MAT is national training and mentoring project developed in response to the prescription opioid misuse epidemic and the availability of newer pharmacotherapies to address opioid use disorder. The overarching goal of PCSS-MAT is to make available the most effective medication-assisted treatments to serve patients in a variety of settings, including primary care, psychiatric care, and pain management settings. The website can be accessed at: http://pcssmat.org/ |
Public Policy Statement on Pharmacological Therapies for Opioid Use Disorders American Society of Addiction Medicine. April 2013. ![]() ![]() ![]() |
![]() ![]() ![]() American Society of Addiction Medicine August 2014. ![]() ![]() ![]() |
Recovery-Oriented Methadone Maintenance Monograph October 2010. There are growing calls to shift the acute-care model of addiction treatment to a model of sustained recovery support analogous to the long-term management of other chronic diseases. The purpose of this monograph written by William White, MA, and Lisa Mojer-Torres, JD, is to explore what this shift means to the design and delivery of methadone maintenance (MM) treatment and the status of MM treatment and MM patients in the United States. ![]() ![]() ![]() |
Review of the Assessment and Management of Neonatal Abstinence Syndrome Addiction Science and Clinical Practice September 2014. The journal article can be accessed at: http://www.ascpjournal.org/content/9/1/19 |
![]() ![]() ![]() http://www.samhsa.gov/medication-assisted-treatment |
Stigma from the Viewpoint of the Patient Journal of Addictive Diseases June 15, 2015. Joycelyn Sue Woods, MA & Herman Joseph, PhD. http://www.tandfonline.com/doi/full/10.1080/10550887.2015.1059714 PDF file i s also available for download. |
SAMHSA Opioid Overdose Prevention Toolkit Updated September 2014. Download PDF (1.32MB, 24pp) |
![]() ![]() ![]() National Institute on Drug Abuse February 18, 2015. The article can be accessed at: http://www.drugabuse.gov/news-events/nida-notes/2015/02/study-points-to-individualized-therapy-opioid-addiction |
The Case for Expanding Access to Medication-Assisted Treatment to Address the Heroin and Opioid Epidemic Legal Action Center March 2015. Policy paper available |
Transfer from Methadone to Buprenorphine by Paul P. Casadonte, MD PCSS-MAT December 5, 2013. ![]() ![]() ![]() |
Treatment and Prevention of Opioid Use Disorder: Challenges and Opportunities Journal Paper Annual Review of Public Health December 2017. ![]() ![]() ![]() |
Use of Naloxone for the Prevention of Drug Overdose Deaths Policy Statement![]() ![]() ![]() American Society of Addiction Medicine – Revised August 16, 2014. Download PDF (159KB, 6pp) |
Patient Resources
![]() ![]() ![]() A series of three booklets produced in October 2009, by the Substance Abuse and Mental Health Services Administration (SAMHSA)), are designed to provide basic information about MAT for opioid addiction including medication options for treatment – methadone, naltrexone, and buprenorphine. The booklets also explain how medication options fit into the overall recovery process.One booklet is directed at families and friends of patients entering MAT. The other two booklets present facts about naltrexone and buprenorphine and are directed at patients entering MAT. Medication-Assisted Treatment for Opioid Addiction – Facts for Families and Friends ![]() ![]() ![]() August 2009. Substance Abuse Mental Health Services Administration (SAMHSA) |
“The Joy of Being Normal” – Short Video Paints Positive MMT Portrait This is a short (7 1/3 minutes) video that illustrates the benefits of methadone as a medication allowing people to live normal and productive lives. Several vignettes reveal examples of “secret successes” that have so often been hidden from public view – MMT patients flourishing in everyday life, with responsible jobs and loving families. Available online at: https://www.youtube.com/watch?v=1LSqVT34yQo |
Updated MAT Primer for Patients from DPA About Methadone and Buprenorphine is a revised (2006) 50-page booklet from the Drug Policy Alliance (DPA) that covers most of the questions patients and their loved ones might have about Medication-Assisted Treatment (MAT). There also is a brief discussion on buprenorphine, added in this 2nd edition. Written in nontechnical language, it gives facts, dispels myths, and also provides helpful tips on such topics as traveling with methadone, storing the drug, concerns about overdose, and much more. To obtain copies, contact the Drug Policy Alliance at 212-613-8020; e-mail to Visit the DPA publications library where you can download a PDF file copy of the booklet. |
All links accessed December 2018.